Wealthfront Advisers LLC Takes $605,000 Position in The Cooper Companies, Inc. $COO

Wealthfront Advisers LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 8,430 shares of the medical device company’s stock, valued at approximately $605,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. New York Life Investment Management LLC boosted its position in Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the last quarter. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Essential Partners LLC increased its position in shares of Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock worth $62,000 after acquiring an additional 166 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO opened at $76.22 on Friday. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a market cap of $14.87 billion, a price-to-earnings ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83. The stock has a 50 day moving average of $71.93 and a 200-day moving average of $71.16.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the company posted $0.96 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on COO shares. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. BNP Paribas Exane reduced their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.